Pharmaceutical Industry Under NAFTA: trade competitiveness and production of proprietary knowledge

Authors

  • Rodrigo Armando Guerrero Castro Universidad Autónoma Metropolitana-Unidad Xochimilco

Keywords:

Pharmaceutical industry, trade, technology, industrial property, TRIPs

Abstract

In this paper we analyze the competitiveness of the pharmaceutical sector in Mexico, USA and Canada, before and since the operation start of NAFTA, based in the TradeCAN. It also approaches the implications that the pharmaceutical industry had when the TRIPs/WTO agreement took place.

A parallel analysis performed in the present study is to quantify the production of patented knowledge by nationality of firms in the U.S. pharmaceutical market (USPTO) and the Mexican one (IMPI).

Therefore, the work is developed in the following order: a) competitiveness through TradeCAN b) trade balance, inputs as well as final products; c) analysis of technological innovation through patented knowledge production; and finally d) the conclusions presentation.

Author Biography

Rodrigo Armando Guerrero Castro, Universidad Autónoma Metropolitana-Unidad Xochimilco

Maestro en Economía y Gestión de la Innovación, Universidad Autónoma Metropolitana

Published

2012-12-13

Issue

Section

Science article